FULC Fulcrum Therapeutics Inc

USD 3.56 -0.08 ( -2.20)%
Icon

Fulcrum Therapeutics Inc (FULC) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

Buy

Average Analyst
Rating
stockTargetAdvisor

Buy

Top Analyst
Rating
stockTargetAdvisor

Very Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 3.56

-0.08 (-2.20)%

N/A

0.87M

USD 10.70(+200.56%)

USD 9.33 (+162.08%)

Icon

FULC

Fulcrum Therapeutics Inc (USD)
COMMON STOCK | NSD
USD 3.56
-0.08 ( -2.20)%
stockTargetAdvisor

Buy

Average Analyst
Rating
stockTargetAdvisor

Buy

Top Analyst
Rating
stockTargetAdvisor

Very Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

N/A

USD 9.33 (+162.08%)

USD 3.56

Fulcrum Therapeutics Inc (FULC) Stock Forecast

Show ratings and price targets of :
USD 10.70
(+200.56%)

Based on the Fulcrum Therapeutics Inc stock forecast from 7 analysts, the average analyst target price for Fulcrum Therapeutics Inc is USD 10.70 over the next 12 months. Fulcrum Therapeutics Inc’s average analyst rating is Buy . Stock Target Advisor’s own stock analysis of Fulcrum Therapeutics Inc is Very Bearish, which is based on 0 positive signals and 2 negative signals. At the last closing, Fulcrum Therapeutics Inc’s stock price was USD 3.56. Fulcrum Therapeutics Inc’s stock price has changed by +3.79% over the past week, +2.30% over the past month and +2.59% over the last year.

No recent analyst target price found for Fulcrum Therapeutics Inc
No recent average analyst rating found for Fulcrum Therapeutics Inc

Company Overview Fulcrum Therapeutics Inc

N/A

N/A

N/A

N/A

USD

USA

Adjusted Closing Price for Fulcrum Therapeutics Inc (FULC)

Loading...

Unadjusted Closing Price for Fulcrum Therapeutics Inc (FULC)

Loading...

Share Trading Volume for Fulcrum Therapeutics Inc Shares

Loading...

Compare Performance of Fulcrum Therapeutics Inc Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for FULC

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Fulcrum Therapeutics Inc (Sector: Biotechnology )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
VRTX
Vertex Pharmaceuticals Inc +4.61 (+0.94%) USD121.60B 32.57 250.99

Frequently Asked Questions About Fulcrum Therapeutics Inc (FULC) Stock

Based on ratings from 7 analysts Fulcrum Therapeutics Inc's stock is Buy . Stock Target Advisor's fundamental analysis is Very Bearish. The stock has 3 buy, sell and 7 hold ratings.

Unfortunately we do not have enough data on FULC's stock to indicate if its a good dividend stock.

Based on targets from 7 analysts, the average taret price for FULC is USD 10.70 over the next 12 months. The maximum analyst target price is USD 23 while the minimum anlayst target price is USD 3.

Unfortunately we do not have enough data on FULC's stock to indicate if its overvalued.

The last closing price of FULC's stock was USD 3.56.

Unfortunately we do not currently have any market capitalization data for FULC's stock.

Based on targets from 7 analysts, the average taret price for FULC is projected at USD 10.70 over the next 12 months. This means that FULC's stock price may go up by +200.56% over the next 12 months.

We can't find any ETFs which contains Fulcrum Therapeutics Inc's stock.

Sorry, we do not have any data on the number of employees for Fulcrum Therapeutics Inc.

Sorry we do not have any infomation available on Fulcrum Therapeutics Inc's address.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Frequently Asked Questions About Fulcrum Therapeutics Inc (FULC) Stock

Based on ratings from 7 analysts Fulcrum Therapeutics Inc's stock is Buy . Stock Target Advisor's fundamental analysis is Very Bearish. The stock has 3 buy, sell and 7 hold ratings.

Unfortunately we do not have enough data on FULC's stock to indicate if its a good dividend stock.

Based on targets from 7 analysts, the average taret price for FULC is USD 10.70 over the next 12 months. The maximum analyst target price is USD 23 while the minimum anlayst target price is USD 3.

Unfortunately we do not have enough data on FULC's stock to indicate if its overvalued.

The last closing price of FULC's stock was USD 3.56.

Unfortunately we do not currently have any market capitalization data for FULC's stock.

Based on targets from 7 analysts, the average taret price for FULC is projected at USD 10.70 over the next 12 months. This means that FULC's stock price may go up by +200.56% over the next 12 months.

We can't find any ETFs which contains Fulcrum Therapeutics Inc's stock.

Sorry, we do not have any data on the number of employees for Fulcrum Therapeutics Inc.

Sorry we do not have any infomation available on Fulcrum Therapeutics Inc's address.
Loading...